Abhishek Kumar

Abhishek Kumar

Auto-generated profile, based on publicly available information

Abhishek Kumar

Department of Pharmacology, Gurukul Institute of Pharmaceutical Science and Research, Gwalior, India

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2026 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
AKAbhishek Kumar
Abhishek Kumar
ASAman Shrivastava
Aman Shrivastava
ASAshish Suttee
Ashish Suttee
PGParas Gupta
Paras Gupta
SSSanyogita Shahi
Sanyogita Shahi
DDDr. Sumeet Dwivedi
Dr. Sumeet Dwivedi
Plant-powered nanotechnologies integrate the concepts of biological engineering and green synthesis to produce safe and environmentally friendly nanoparticles that address environmental and public health issues. Biological production, meanwhile, is a safe, biodegradable, as well as a sustainable method to create nanoparticles. Tabernaemontana divaricate, Calotropis gigantea (L.), Passiflora caerulea, Acorus calamus (rhizome), Cucurbita maxima (petals), Moringa oleifera (leaves), Piper nigrum, Ziziphus Spina Christi, Eucalyptus globulus, and Ziziphus oenoplia, etc., plants were among the medicinal flora used in the biological synthesis of Silver and Zinc oxide. Initially, phytochemical testing, scanning electron microscopy, energy-dispersive X-ray spectroscopy (EDS), X-ray diffraction, and electron microscopy were employed to characterize the greensynthesized Zinc oxide and silver nanoparticles. These medicinal floras have proven tremendous potential in the development of nanoparticles for several purposes in medicine, cosmeceuticals, food science and technology, water treatment and purification, environmental cleanup, and agriculture. This review paper highlights the characteristics of biologically produced Zinc oxide and Silver Nanoparticles and investigates the broad spectrum of plants that can be utilized in a single-phase, rapid protocol preparation approach that prioritizes green principles over conventional ones. These biologically friendly silver and zinc oxide nanoparticles have the potential to be very useful in the field of biomedicine, agriculture, cosmetics, water treatment, food science and technology, and the energy sector. The biomedicinal applications of green synthesised nanoparticles are particularly intriguing, with potential in drug delivery, bioimaging, antibacterial treatments, anti-Leishmanial properties, and cancer therapy. Compared to previous approaches, these nanoparticles provide benefits in terms of controlled administration, less toxicity, and increased therapeutic effectiveness. Future studies must concentrate on the development of affordable, non-hazardous, ecologically safe, and self-degradable nanoparticles to aid in the commercialisation of nanotechnology in agriculture, food, healthcare, and energy.


16 March 2026 in Current Nanomedicine
Verified
Journal Article
Closed access
AKAbhishek Kumar
Abhishek Kumar
ASAman Shrivastava
Aman Shrivastava
RCRahul Chaurasia
Rahul Chaurasia
RBRakesh Barik
Rakesh Barik
PGParas Gupta
Paras Gupta
DDDr. Sumeet Dwivedi
Dr. Sumeet Dwivedi
Introduction: Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the selective loss of dopaminergic neurons in the substantia nigra. This common neurodegenerative illness, which commonly develops in individuals approximately fifty years old and is characterized by cognitive or motor abnormalities, comprises speech difficulties and gait problems as symptoms. Methods: The Study selection focused on identifying relevant literature discussing the application of solid lipid nanoparticles (SLNs) for nose-to-brain drug delivery in Parkinson’s disease. Peer-reviewed articles, reviews, and experimental studies highlighting the advantages of SLNs in bypassing the blood-brain barrier and enhancing central nervous system drug targeting were thoroughly reviewed. Results: Solid lipid-based nanocarriers have been proposed as an effective nose-to-brain drug delivery approach, enabling the safe and site-specific administration of therapeutic agents for Parkinson’s disease. The nervous system may absorb them due to their lipophilic characteristics. Furthermore, biocompatible and biodegradable, they may decrease the metabolism of loaded drugs, enhancing their stability. Through improved drug solubility, permeability across the bloodbrain barrier, and an extended half-life in circulation. Discussion: In the current review, the intranasal approach was selected to facilitate the delivery of medication to the CNS. Conclusion: NBDD enables direct drug delivery to the brain via the olfactory and trigeminal nerve pathways, bypassing the blood-brain barrier and avoiding first-pass metabolism and gastrointestinal degradation. This results in faster onset of action and rapid drug absorption, as well as increased concentrations of drugs along with bioavailability of the brain, which lowers dosage as well as systemic side effects.

29 September 2026 in DARU Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
AKAbhishek Kumar
Abhishek Kumar
ASAman Shrivastava
Aman Shrivastava
VKVinay Kumar
Vinay Kumar
PGParas Gupta
Paras Gupta
RBRakesh Barik
Rakesh Barik
JGJeetendra Kumar Gupta
Jeetendra Kumar Gupta